Publications by authors named "Daniel Trageser"

Claim this Profile
A
Author Correction: Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia.
Srividya Swaminathan, Lars Klemm, Eugene Park, Elli Papaemmanuil, Anthony Ford, Daniel Trageser

Nat Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.
Sied Kebir, Vivien Ullrich, Pia Berger, Celia Dobersalske, Sarah Langer, Daniel Trageser

Clin Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma.
Roman Reinartz, Shanshan Wang, Sied Kebir, Daniel J Silver, Anja Wieland, Daniel Trageser

Clin Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia.
Srividya Swaminathan, Lars Klemm, Eugene Park, Elli Papaemmanuil, Anthony Ford, Daniel Trageser

Nat Immunol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer effects of niclosamide in human glioblastoma.
Anja Wieland, Daniel Trageser, Sabine Gogolok, Roman Reinartz, Heike Höfer

Clin Cancer Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma.
Martin Glas, Christoph Coch, Daniel Trageser, Juliane Dassler, Matthias Simon

Stem Cells· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.
Dat T Vo, Kotb Abdelmohsen, Jennifer L Martindale, Mei Qiao, Kumiko Tominaga, Daniel Trageser

Mol Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
Yunqing Li, Angela Li, Martin Glas, Bachchu Lal, Mingyao Ying, Daniel Trageser

Proc Natl Acad Sci U S A· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual tumor cells are unique cellular targets in glioblastoma.
Martin Glas, Barbara H Rath, Matthias Simon, Roman Reinartz, Anja Schramme, Daniel Trageser

Ann Neurol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.
Daniel Trageser, Ilaria Iacobucci, Rahul Nahar, Cihangir Duy, Gregor von Levetzow

J Exp Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia.
Pavinder Kaur, Niklas Feldhahn, Bin Zhang, Daniel Trageser, Markus Müschen

Mol Cancer· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis